|
GENEED, INC. AND SEERPHARMA
SIGN JOINT DISTRIBUTION AGREEMENT
- GeneEd, Inc. to sell SeerPharma's Regulatory and
Compliance Courses in the US and Canada
- SeerPharma to sell GeneEd's Therapeutic Area Courses in Asia, the UK,
and Ireland
San Francisco, CA, June 18, 2007 – GeneEd, Inc.,
a leading provider of online learning for the Life Sciences, has signed
a strategic partnership with SeerPharma, Asia Pacific’s largest
professional consultancy in the areas of technical compliance and validation,
QA knowledge, and training solutions for the pharmaceutical, medical device,
and biotechnology industries.
According to the terms of the partnership, GeneEd will distribute SeerPharma’s
online regulatory and compliance curriculum in the US and Canada; SeerPharma
will distribute GeneEd’s online curriculum of therapeutic area courses
in Australia, New Zealand, Malaysia, Singapore, South Korea, Ireland,
and the UK.
“The SeerPharma curriculum significantly expands our ability to
address regulatory and compliance issues across the Drug Development pipeline,”
said GeneEd’s Chief Scientific Officer, Alycia Shilton-Lloyd. “Our
current regulatory and compliance courses, designed for R&C training
in the Development, Pre-clinical, or Clinical phases of drug development,
will now be strengthened by SeerPharma’s curriculum that provides
a much more detailed offering in the area of Clinical and Commercial Manufacturing.”
Donovan Weare, CEO of SeerPharma, said, “GeneEd’s catalog
of nearly 150 therapeutic area courses opens up an exciting line of new
products for our company. Covering disease states in areas as diverse
as Neuropathic Pain, Viral Infection, and Oncology, the GeneEd Therapeutic
Area catalog will allow us to offer highly interactive, medically validated
content to a geographically diverse audience.”
SeerPharma’s GMP series contains nine modules including Documentation
and Record Keeping, Contamination Control, and Quality Assurance and Quality
Control. The GLP series also consists of nine modules ranging from and
Introduction to G(QC)LP through Stability Programs and Microbiology Laboratory
Techniques. The ten modules of the Validation Series include topics on
Validation Master Plans and Documentation, Validation Principles/International
Regulations, and Computer Systems Validation. Other modules comprise the
IS/IT series, and the upcoming Medical Device series.
ABOUT GENE ED, INC. – GeneEd is an e-Learning provider for the
biopharmaceutical industry, with several clients whom are Fortune 500
companies. The company’s CME courses span the entire pharmaceutical
development pipeline and healthcare-education spectrum. The GeneEd Regulatory
and Compliance courses provide GxP training for clinical sites, CRAs,
and management. For more information regarding this, or any other programs
offered by GeneEd, please contact Alycia Shilton-Lloyd or visit: www.geneed.com.
ABOUT SEERPHARMA- SeerPharma provides integrated solutions in compliance
training and consulting expertise for the Pharmaceutical, Biotechnology
and Medical Device industries as well as QA software solutions, risk management
and validation services. For more information regarding SeerPharma’s
online learning and other services please contact Steve Williams or visit:
www.seerpharma.com.au
Main Web sites: www.geneed.com and www.seerpharma.com
E-mail: info@geneed.com and steve.williams@seerpharma.com.au
(Flash is a trademark of Macromedia Corp/Adobe Inc.)
|
